Versant Capital Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$136K Buy
2,330
+42
+2% +$2.34K 0.01% 790
2026
Q2
$124K Buy
2,288
+552
+32% +$26.9K 0.01% 813
2026
Q1
$74.5K Buy
1,736
+105
+6% +$4.51K 0.01% 1015
2025
Q4
$71.5K Hold
1,631
– – 0.01% 905
2025
Q3
$67.4K Buy
1,631
+1,008
+162% +$40.5K 0.01% 891
2025
Q2
$27.5K Buy
623
+319
+105% +$12.8K ﹤0.01% 1341
2025
Q1
$11.2K Buy
304
+66
+28% +$2.35K ﹤0.01% 1667
2024
Q4
$7.92K Hold
238
– – ﹤0.01% 1529
2024
Q3
$6.18K Hold
238
– – ﹤0.01% 1223
2024
Q2
$5.35K Buy
238
+230
+2,875% +$5.1K ﹤0.01% 1197
2024
Q1
$190 Hold
8
– – ﹤0.01% 1833
2023
Q4
$192 Hold
8
– – ﹤0.01% 1874
2023
Q3
$175 Sell
8
-30
-79% -$628 ﹤0.01% 1888
2023
Q2
$726 Buy
+38
New +$732 ﹤0.01% 1720
2021
Q3
– Sell
-61
Closed -$1K – 1498
2021
Q2
$1K Buy
+61
New +$1.42K ﹤0.01% 1269

Other funds holding EXEL

Versant Capital Management's EXEL Position: Q3 2026 in Review

Versant Capital Management increased its Exelixis (EXEL) stake by 1.8% in Q3 2026, buying an estimated $2.34K and bringing the position to 2,330 shares worth $136K. The position accounts for 0.01% of the portfolio, ranked #790.

Versant Capital Management first reported a position in EXEL in Q2 2021 and has held it in 15 quarters since. 458 funds tracked by Wall St. Rank hold EXEL as of Q3 2026.

  • Versant Capital Management held 2,330 shares of Exelixis worth $136K as of Q3 2026.
  • Versant Capital Management bought 42 Exelixis shares in Q3 2026, an estimated $2.34K.
  • Exelixis made up 0.01% of Versant Capital Management's portfolio in Q3 2026, its #790 holding.
  • Versant Capital Management first reported a position in Exelixis in Q2 2021 and has held it in 15 quarters since.
  • 458 funds tracked by Wall St. Rank held Exelixis as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.